O001 Randomized, double-blind, placebo-controlled trial of recombinant human C1 inhibitor for prophylaxis of hereditary angioedema attacks

Publication date: November 2016
Source:Annals of Allergy, Asthma & Immunology, Volume 117, Issue 5, Supplement
Author(s): M. Cicardi, M. Riedl, V. Grivcheva Panovska, D. Moldovan, J. Baker, W. Yang, A. Reshef, S. Andrejevic, R. Lockey, R. Hakl, S. Kivity, L. Bellizzi, J. Harper, A. Relan




http://ift.tt/2fqwlNi